obesity

Novo valuation surpasses Tesla on experimental obesity drug data
Reuters
Thu, 03/7/24 - 11:40 am
Novo Nordisk
obesity
weight loss
clinical trials
amycretin
Empros Pharma's Breakthrough: Over 8% Weight Loss in Novel Oral Agent Trial
BNN
Tue, 03/5/24 - 11:51 am
Empros Pharma
obesity
weight loss
clinical trials
Orlistat
acarbose
Americans don't think weight-loss drugs will fix the obesity epidemic
Axios
Wed, 02/28/24 - 10:44 am
obesity
weight loss
Ozempic
Wegovy
Zepbound
GLP-1 agonist
Weight-loss drugs could boost US GDP by 1% in coming years, Goldman says
Reuters
Thu, 02/22/24 - 11:14 pm
obesity
weight loss
GLP-1 agonist
Novo Nordisk
Eli Lilly
Novo Nordisk, Eli Lilly lead industrywide sales surge in Q4
Fierce Pharma
Thu, 02/22/24 - 11:12 pm
earnings
Novo Nordisk
Eli Lilly
obesity
India pharma companies develop versions of Wegovy to get in on weight-loss windfall
Reuters
Thu, 02/22/24 - 11:29 am
India
Wegovy
drug development
obesity
weight loss
Eli Lilly Has More Than an Ozempic Competitor -- Much More
Motley Fool
Wed, 02/21/24 - 11:14 am
Eli Lilly
obesity
cancer
diabetes
psoriasis
Alzheimer's disease
Should ACA plans cover weight loss drugs?
Stat
Tue, 02/20/24 - 05:44 pm
ACA
Obamacare
weight loss
obesity
CMS
Wegovy
Mounjaro
Eli Lilly partner BioAge raises $170 mln for obesity treatment
Reuters
Tue, 02/13/24 - 11:24 am
BioAge Labs
Eli Lilly
obesity
funding
Obesity drug mania takes over Amgen’s earnings call
BioPharma Dive
Wed, 02/7/24 - 09:17 pm
Amgen
earnings
GLP-1 agonist
obesity
AMG-133
Could Novo, Lilly become first trillion-dollar healthcare companies?
Pharma Voice
Mon, 02/5/24 - 10:30 am
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Mounjaro
obesity
weight loss
Regeneron Looks to Target Weight Loss Market with Muscle-Preserving Antibodies
BioSpace
Mon, 02/5/24 - 10:20 am
Regeneron
obesity
muscle
drug development
Fractyl Breaks the Medical Device IPO Drought with New Offering
Medical Devices and Diagnostics Industry
Sun, 02/4/24 - 12:37 pm
Fractyl Health
IPOs
diabetes
obesity
Medtech
FDA approves NeuroBo’s DA-1726 application to begin Phase I trial
Clinical Trials Arena
Fri, 02/2/24 - 11:55 am
NeuroBo Pharmaceuticals
DA-1726
FDA
clinical trials
obesity
Novo Nordisk R&D spend jumps 35% thanks to soaring sales as oral obesity plans advance
Fierce Biotech
Wed, 01/31/24 - 11:55 am
Novo Nordisk
R&D
obesity
amycretin
Will Novo Nordisk Be a $1 Trillion Company by 2030?
Motley Fool
Tue, 01/30/24 - 10:40 am
Novo Nordisk
obesity
diabetes
kidney disease
Fractyl sets out $99M IPO ambitions after busy week of biotechs going public
Fierce Biotech
Mon, 01/29/24 - 11:13 am
IPOs
Fractyl Health
obesity
Lilly's weight-loss drug Mounjaro coming to UK after pen cleared
Reuters
Thu, 01/25/24 - 09:00 pm
Eli Lilly
Mounjaro
UK
obesity
diabetes
Many patients keep weight off after stopping anti-obesity meds: study
Axios
Wed, 01/24/24 - 10:44 am
obesity
Novo Nordisk
Ozempic
Wegovy
Saxenda
Victoza
Scholar Rock gets FDA nod to trial SMA drug with GLP-1ra in obesity
Clinical Trials Arena
Wed, 01/24/24 - 10:38 am
Scholar Rock
clinical trials
apitegromab
obesity

Pages